Faster Walking Pace Cuts Risk for Cardiac Arrhythmias
By Lori Solomon HealthDay Reporter
FRIDAY, April 25, 2025 -- Average and brisk walking pace are associated with a decreased risk for cardiac arrhythmias, according to a study published online April 15 in Heart.
Pei Qin, Ph.D., from the University of Glasgow in the United Kingdom, and colleagues assessed associations between self-reported and accelerometer-measured walking pace and incident cardiac arrhythmias. The analysis included self-reported data for 420,925 U.K. Biobank participants and accelerometer data for 81,956 participants.
The researchers found that compared with slow walking pace (<3 miles per hour), average and brisk walking pace (3 to 4 miles per hour and >4 miles per hour, respectively) were associated with significantly lower risks for all cardiac arrhythmias (hazard ratio [HR], 0.65 and 0.57, respectively), atrial fibrillation (HR, 0.62 and 0.54, respectively), and other arrhythmias (HR, 0.69 and 0.61, respectively). Just over one-third of the association between walking pace and all arrhythmias (36.0 percent) was mediated by metabolic and inflammatory markers. Associations were even stronger for women, those aged younger than 60 years, those with a body mass index <30, those with hypertension, and those with two or more long-term conditions.
"These new findings reinforce the promotion of faster walking pace in physical activity recommendations that walking at a brisk pace may have a role in secondary, as well as primary, prevention of cardiac arrhythmias, and provide evidence of higher-risk groups to target," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
Study Compares Benefits, Harms of Treatments for Chronic Hives
WEDNESDAY, July 23, 2025 -- Omalizumab and remibrutinib may be the most effective treatments for reducing hives, itch, and swelling with chronic urticaria, according to a study...
USPSTF Guidelines of Little Value for Estimating Preeclampsia Risk in Those at Moderate Risk
WEDNESDAY, July 23, 2025 -- Moderate U.S. Preventive Services Task Force (USPSTF) preeclampsia risk factors have little value for estimating the risk for preeclampsia, according...
Endocrine Society, July 12-15
The annual meeting of the Endocrine Society (ENDO 2025) was held from July 12 to 15 in San Francisco, attracting more than 7,000 participants, including clinicians, academicians...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.